Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease

Por Bor, Renáta, Farkas, Klaudia, Fábián, Anna, Bálint, Anita, Milassin, Ágnes, Rutka, Mariann, Matuz, Mária, Nagy, Ferenc, Szepes, Zoltán, Molnár, Tamás
Publicado no PLoS One (2017)

Rectal Tumour Staging with Endorectal Ultrasound: Is There Any Difference between Western and Eastern European Countries?

Por Fábián, Anna, Bor, Renáta, Farkas, Klaudia, Bálint, Anita, Milassin, Ágnes, Rutka, Mariann, Tiszlavicz, László, Wittmann, Tibor, Nagy, Ferenc, Molnár, Tamás, Szepes, Zoltán
Publicado no Gastroenterol Res Pract (2016)

Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum

Por Rutka, Mariann, Bor, Renáta, Bálint, Anita, Fábián, Anna, Milassin, Ágnes, Nagy, Ferenc, Szepes, Zoltán, Szűcs, Mónika, Tiszlavicz, László, Farkas, Klaudia, Molnár, Tamás
Publicado no Mediators Inflamm (2016)

A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer

Por Annaházi, Anita, Ábrahám, Szabolcs, Farkas, Klaudia, Rosztóczy, András, Inczefi, Orsolya, Földesi, Imre, Szűcs, Mónika, Rutka, Mariann, Theodorou, Vassilia, Eutamene, Helene, Bueno, Lionel, Lázár, György, Wittmann, Tibor, Molnár, Tamás, Róka, Richárd
Publicado no Br J Cancer (2016)